Mark G. Federici

Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer

Marie Plante, Stephen C. Rubin, George Y. Wong et al. · Cancer · 1994 · 176 citations · Full text

Medicine, Immunology, Oncology +15

Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens fromBRCA1 heterozygotes

Richard R. Barakat, Mark G. Federici, Patricia E. Saigo et al. · Cancer · 2000 · 102 citations · Full text

Medicine, Oncology, Pathology +17

Serological and immunochemical analysis of Lewis Y (Ley) blood group antigen expression in epithelial ovarian cancer

Beatrice W.T. Yin, Connie L. Finstad, Kunio Kitamura et al. · International Journal of Cancer · 1996 · 94 citations

Medicine, Oncology, Pathology +15

Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome

Jeff Boyd, Esther Rhei, Mark G. Federici et al. · Breast Cancer Research and Treatment · 1999 · 91 citations

Medicine, Genetics, Oncology +14

Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer

Stephen C. Rubin, Connie L. Finstad, Mark G. Federici et al. · Cancer · 1994 · 66 citations

Medicine, Gynecology, Oncology +13